PITTSBURGH, PA, Abridge, the leader in medical conversation AI, today announced an oversubscribed $12.5 million Series A-1.
Led by Wittington Ventures, the round also had participation from all existing investors including Union Square Ventures, Bessemer Venture Partners, Pillar Venture Capital, and UPMC Enterprises, and new investors including Turing Award winner Yoshua Bengio, and Whistler Capital. Abridge's enterprise-focused documentation solutions seamlessly structure and summarize information from any medical conversation, making it easier for systems to reduce provider burnout while also increasing patient satisfaction. Armed with a proprietary dataset derived from more than 1.5 million medical encounters and more peer-reviewed papers about medical conversation AI than any other entity, Abridge has already helped more than 2,000 clinicians practice at the top of their license and 200,000 patients stay on top of their health.
Abridge structures and summarizes information from the most important signals in healthcare - spoken conversations. Abridge's technology is powered by industry-leading R&D, as evidenced by their depth of peer-reviewed publications in medical conversation AI and user experience design. The company's audio and ambient AI-centered solutions help clinicians practice at the top of their license and patients stay on top of their health. Whether an appointment takes place in-person or via telemedicine, Abridge captures and documents the conversation to meet the needs of providers, patients, and enterprises.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.